REGENERATIVE PRECISION
The Science of iPSC-Derived Extracellular Vesicles
Rejuvenay specializes in bringing advanced iPSC-derived extracellular vesicle technologies to professional healthcare markets through strategic partnerships and scientific collaboration. Built upon established regenerative biotechnology, these biological solutions are designed to support cellular communication, tissue health, and biological resilience across aesthetic medicine, wellness, longevity, and emerging clinical applications. By connecting healthcare professionals and regional distribution partners with advanced regenerative technologies, Rejuvenay helps expand access to the next generation of biological innovation.
BIOLOGICAL RENEWAL
The iPSC-EV Solution
iPSC-derived extracellular vesicles represent an important advancement in regenerative biotechnology, offering a sophisticated approach to supporting cellular communication and biological signaling. Through naturally occurring bioactive molecules—including growth factors, cytokines, proteins, and regulatory microRNAs—these extracellular vesicles help coordinate biological processes associated with tissue health, repair, and cellular resilience.
The regenerative biotechnology solutions introduced through Rejuvenay are selected for their scientific foundation, manufacturing quality, and application-specific performance. Manufactured under rigorous GMP-grade quality systems, these formulations are designed to deliver consistent biological activity while supporting professional applications across aesthetic medicine, wellness, longevity, and emerging clinical fields.
THE METHODOLOGY
The Biological Regeneration Sequence
01
02
03
Isolation
Targeting
Biological Response
iPSC-derived extracellular vesicles are carefully isolated and purified under rigorous manufacturing standards to help ensure consistency, biological integrity, and application-specific quality.
These biologically active extracellular vesicles support cellular communication through naturally occurring signaling molecules, helping coordinate biological processes associated with tissue health and cellular function.
Through complex biological signaling pathways, extracellular vesicles help support cellular communication and physiological processes associated with tissue maintenance, resilience, and normal biological function.
The following sequence illustrates the biological processes through which iPSC-derived extracellular vesicles are understood to support cellular communication and regenerative activity.
CLINICAL VALIDATION
iPSC-derived extracellular vesicle technology is supported by a growing body of scientific research spanning regenerative medicine, cellular biology, and translational medicine. Together, these studies continue to expand our understanding of extracellular vesicle biology and its potential across professional healthcare applications.
240%
collagen synthesis increase
82%
cellular repair acceleration
12x
vesicle absorption rate
Rigorous biological evidence
What are iPSC-derived extracellular vesicles?
These are nano-sized biological extracellular vesicles harvested from induced pluripotent stem cells (iPSCs). They contain a complex profile of naturally occurring proteins, lipids, growth factors, cytokines, and regulatory RNA molecules that support cellular communication and biological signaling. Through these naturally occurring bioactive components, extracellular vesicles help support the body's natural cellular communication processes involved in tissue homeostasis and biological renewal.
COMMON INQUIRIES
Scientific Clarity
How does this differ from standard skincare?
Unlike conventional skincare products that primarily act on the skin's surface, iPSC-derived extracellular vesicles are designed to support cellular communication through biologically active signaling molecules. Their purpose is to help promote the skin's natural renewal processes by supporting normal cellular function rather than simply providing topical hydration or protection.
Is the technology backed by research?
Yes. iPSC-derived extracellular vesicle technology is supported by a growing body of preclinical and emerging clinical research investigating its biological activity and potential applications. Scientific understanding continues to evolve as additional studies are published. Rejuvenay is committed to supporting the responsible commercialization of regenerative biotechnology solutions informed by current scientific evidence and rigorous quality standards.
Is this the same as stem cell therapy?
No. iPSC-derived extracellular vesicles are not stem cells and contain no living cells or DNA capable of replication. Instead, they are naturally occurring biological messengers that support cellular communication through bioactive signaling molecules. This cell-free approach is designed to leverage the biological benefits associated with extracellular vesicles while maintaining a favorable safety profile.
Where do the iPSCs come from?
The induced pluripotent stem cells (iPSCs) used in the manufacturing process are reprogrammed from ethically sourced adult donor cells, such as blood cells, rather than embryonic stem cell sources. This approach avoids the ethical considerations associated with embryonic tissue while preserving the unique biological characteristics of pluripotent stem cells.
Is it safe that these come from human donor cells?
Yes. All donor material undergoes comprehensive biological screening and safety testing before processing. Throughout manufacturing, stringent quality-control procedures are applied to ensure consistency, purity, and biological integrity. The resulting extracellular vesicles undergo extensive purification and are tested for contaminants, including bacteria, fungi, endotoxins, and other critical safety parameters prior to release.
How does this compare to other extracellular vesicle sources?
Extracellular vesicles can be derived from a variety of biological sources, including plant, animal, and adult human tissues. iPSC-derived extracellular vesicles offer advantages in manufacturing consistency because they originate from stable, individually screened donor-derived cell lines rather than variable tissue sources. This consistency supports standardized production, reproducible quality, and reliable performance for professional healthcare applications.